This article discusses the TTAB's decision in Bayer regarding how and when a foreign trademark can be used.
Related Professionals
-
Partner and National Co-Chair, Trademark/Copyright/Privacy Group+1.212.940.8554
-
Related Practices
Related Industries
Related Offices
Recent Articles
-
Evaluating Nasdaq Tokenization Rule's Potential Impact
November 20, 2025
-
Tying down the Gullivers: tripartite strategic balancing in unipolar international systems
November 19, 2025
-
Repertoire of the Practice of the Security Council
November 19, 2025